Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP

Medical Oncology

Volumn 27, Issue 3, 2010, Pages 942-945

  Dincol, Dilek ^a   Buyukcelik, Abdullah ^a   Dogan, Mutlu ^a   Akbulut, Hakan ^a   Samur, Mustafa ^b   Demirkazik, Ahmet ^a   Senler, Filiz Cay ^a   Onur, Handan ^a   Icli, Fikri ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Consolidation; Etoposide; Ifosphamide; Neoplasia; Non Hodgkin lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; DEATH; DISEASE FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; KAPLAN-MEIER ESTIMATE; LYMPHOMA, NON-HODGKIN; MALE; MESNA; MIDDLE AGED; MITOXANTRONE; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDNISOLONE; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; TREATMENT OUTCOME; VINCRISTINE;

EID: 77956899102     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9313-x     Document Type: Article

References (10)

1. J Rodriguez A Gutierrez 2007 New treatment concepts in diffuse large B-cell lymphomas (DLBL): chemotherapy and biological therapy Rev Recent Clin Trials 2 149 162 10.2174/157488707780599348 1:CAS:528:DC%2BD2sXms1OisrY%3D 18474000
2. RI Fisher, et al. 1993 Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma N Eng J Med 328 1002 1006 10.1056/NEJM199304083281404 1:STN:280:DyaK3s7ps1Kmtg%3D%3D (Pubitemid 23095683)
3. F Cabannillas 1990 Ifosfamide combinations in lymphoma Semin Oncol 17 supp 10 58 62
4. G Enblad H Hagberg B Glimelius 1996 Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for non-Hodgkin's lymphomas: a Swedish national prospective study. Swedish Lymphoma Group Acta Oncol 35 165 170 10.3109/02841869609098497 1:STN:280:DyaK283htFentw%3D%3D 8639311
5. D Dincol, et al. 1995 Mesna/ifosfamide, mitoxantrone, etoposide, bleomycin, vincristine and prednisone (MINE-BOP) combination chemotherapy in the treatment of refractory and relapsed non-Hodgkin's lymphoma Acta Oncol 34 937 940 10.3109/02841869509127208 1:STN:280:DyaK28%2FoslSiug%3D%3D 7492384
6. M Pfreundschuh The German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL), et al. 2004 Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL Blood 104 626 633 10.1182/blood-2003-06-2094 1:CAS:528:DC%2BD2cXmtlCkt7k%3D 14982884 (Pubitemid 38970553)
7. A Buyukcelik, et al. 2002 The effect of MINE (Mesna, ifosfamide, mitoxantrone, etoposide) regimen as consolidation treatment in patients with aggressive non- Hodgkin lymphomas responding to CHOP Ann Oncol 13 suppl 5 454
8. B Coiffier, et al. 1989 LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma J Clin Oncol 7 1018 1026 1:STN:280:DyaL1MzivVCktA%3D%3D 2474057
9. D Dincol, et al. 1997 Results of the cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) +- bleomycin treatment and evaluation of prognostic factors in aggressive lymphomas in Turkey Oncology 54 376 379 10.1159/000227722 1:STN:280:DyaK2svgsleltw%3D%3D 9260598
10. The International Non-Hodgkin's Lymphoma Prognostic Factors Project 1993 A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 329 987 994 10.1056/NEJM199309303291402 (Pubitemid 23307906)